← Browse by Condition
Medical Condition
metastatic malignant neoplasm in the peritoneum
Total Trials
4
Recruiting Now
4
Trial Phases
Phase 2, Phase 1
ClinicalMetric tracks all active clinical trials for metastatic malignant neoplasm in the peritoneum sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Trial Phases
Phase 1 2
Phase 2 2
Top Sponsors
2 trials
1 trial
1 trial
NCT05753306 Phase 2
Recruiting
Robotic Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Treatment of Gastric Cancer With Limited Peritoneal Metastasis, ROBO-CHIP Study
Enrollment
40 pts
Location
United States
Sponsor
Mayo Clinic
NCT04811703 Phase 1
Recruiting
Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Associated With Systemic Chemotherapy in Women With Advanced Ovarian Cancer
Enrollment
15 pts
Location
France
Sponsor
Hospices Civils de Lyon
NCT04858009 Phase 2
Recruiting
Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Pancreatic Cancer and Peritoneal Metastasis
Enrollment
40 pts
Location
United States
Sponsor
Mayo Clinic
NCT05285358 Phase 1
Recruiting
Pressurized Intraperitoneal Aerosolized Nab-Paclitaxel in Combination With Gemcitabine and Cisplatin for the Treatment of Biliary Tract Cancer Patients With Peritoneal Metastases
Enrollment
12 pts
Location
United States
Sponsor
City of Hope Medical Center
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology